Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term oral bacterium refers to the diverse community of microorganisms that reside within the human oral cavity, collectively forming the oral microbiome. This ecosystem includes over 700 species of bacteria that typically exist in complex biofilm communities, such as dental plaque, which protect them from environmental stressors and host immune responses (Dewhirst et al., 2010). While most oral bacteria are commensal and contribute to host health by preventing the colonization of exogenous pathogens, an ecological shift or overgrowth of specific species can lead to localized diseases such as dental caries and periodontitis (Marsh, 2003). Furthermore, the translocation of oral bacteria or their inflammatory byproducts into the bloodstream has been linked to systemic conditions, including infective endocarditis, diabetes, and atherosclerosis (Hajishengallis, 2015). Because oral bacterium is a general taxonomic category rather than a specific molecular entity like a receptor or enzyme, it is considered an overly broad designation for a therapeutic target. Pharmacological strategies in this area typically focus on specific bacterial enzymes, metabolic pathways, or the physical disruption of the biofilm matrix (StatPearls, 2023).
Antimicrobial agents targeting oral bacteria function by inhibiting cell wall synthesis, disrupting cytoplasmic membranes, interfering with essential metabolic pathways, or inhibiting protein and DNA synthesis (StatPearls, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral bacterium.